210 related articles for article (PubMed ID: 26114156)
1. Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer.
Yang YA; Yu J
Genes Dis; 2015 Jun; 2(2):144-151. PubMed ID: 26114156
[TBL] [Abstract][Full Text] [Related]
2. Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program.
Jin HJ; Zhao JC; Wu L; Kim J; Yu J
Nat Commun; 2014 May; 5():3972. PubMed ID: 24875621
[TBL] [Abstract][Full Text] [Related]
3. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.
Sahu B; Laakso M; Ovaska K; Mirtti T; Lundin J; Rannikko A; Sankila A; Turunen JP; Lundin M; Konsti J; Vesterinen T; Nordling S; Kallioniemi O; Hautaniemi S; Jänne OA
EMBO J; 2011 Sep; 30(19):3962-76. PubMed ID: 21915096
[TBL] [Abstract][Full Text] [Related]
4. FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression.
Zhao JC; Fong KW; Jin HJ; Yang YA; Kim J; Yu J
Oncogene; 2016 Aug; 35(33):4335-44. PubMed ID: 26751772
[TBL] [Abstract][Full Text] [Related]
5. Pioneer of prostate cancer: past, present and the future of FOXA1.
Teng M; Zhou S; Cai C; Lupien M; He HH
Protein Cell; 2021 Jan; 12(1):29-38. PubMed ID: 32946061
[TBL] [Abstract][Full Text] [Related]
6. FOXA1: a transcription factor with parallel functions in development and cancer.
Bernardo GM; Keri RA
Biosci Rep; 2012 Apr; 32(2):113-30. PubMed ID: 22115363
[TBL] [Abstract][Full Text] [Related]
7. NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression.
Grabowska MM; Elliott AD; DeGraff DJ; Anderson PD; Anumanthan G; Yamashita H; Sun Q; Friedman DB; Hachey DL; Yu X; Sheehan JH; Ahn JM; Raj GV; Piston DW; Gronostajski RM; Matusik RJ
Mol Endocrinol; 2014 Jun; 28(6):949-64. PubMed ID: 24801505
[TBL] [Abstract][Full Text] [Related]
8. Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.
Gui B; Gui F; Takai T; Feng C; Bai X; Fazli L; Dong X; Liu S; Zhang X; Zhang W; Kibel AS; Jia L
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14573-14582. PubMed ID: 31266892
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte nuclear factor-3 alpha (HNF-3alpha) negatively regulates androgen receptor transactivation in prostate cancer cells.
Lee HJ; Hwang M; Chattopadhyay S; Choi HS; Lee K
Biochem Biophys Res Commun; 2008 Mar; 367(2):481-6. PubMed ID: 18178153
[TBL] [Abstract][Full Text] [Related]
10. Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer.
Gao S; Chen S; Han D; Wang Z; Li M; Han W; Besschetnova A; Liu M; Zhou F; Barrett D; Luong MP; Owiredu J; Liang Y; Ahmed M; Petricca J; Patalano S; Macoska JA; Corey E; Chen S; Balk SP; He HH; Cai C
Nat Genet; 2020 Oct; 52(10):1011-1017. PubMed ID: 32868907
[TBL] [Abstract][Full Text] [Related]
11. FOXA1 mutations in hormone-dependent cancers.
Robinson JL; Holmes KA; Carroll JS
Front Oncol; 2013; 3():20. PubMed ID: 23420418
[TBL] [Abstract][Full Text] [Related]
12. Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially.
Yu X; Gupta A; Wang Y; Suzuki K; Mirosevich J; Orgebin-Crist MC; Matusik RJ
Ann N Y Acad Sci; 2005 Dec; 1061():77-93. PubMed ID: 16467259
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific pioneer factors associate with androgen receptor cistromes and transcription programs.
Pihlajamaa P; Sahu B; Lyly L; Aittomäki V; Hautaniemi S; Jänne OA
EMBO J; 2014 Feb; 33(4):312-26. PubMed ID: 24451200
[TBL] [Abstract][Full Text] [Related]
14. Cell-lineage specificity and role of AP-1 in the prostate fibroblast androgen receptor cistrome.
Leach DA; Panagopoulos V; Nash C; Bevan C; Thomson AA; Selth LA; Buchanan G
Mol Cell Endocrinol; 2017 Jan; 439():261-272. PubMed ID: 27634452
[TBL] [Abstract][Full Text] [Related]
15. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.
Parolia A; Cieslik M; Chu SC; Xiao L; Ouchi T; Zhang Y; Wang X; Vats P; Cao X; Pitchiaya S; Su F; Wang R; Feng FY; Wu YM; Lonigro RJ; Robinson DR; Chinnaiyan AM
Nature; 2019 Jul; 571(7765):413-418. PubMed ID: 31243372
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
17. SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin.
Toropainen S; Malinen M; Kaikkonen S; Rytinki M; Jääskeläinen T; Sahu B; Jänne OA; Palvimo JJ
Nucleic Acids Res; 2015 Jan; 43(2):848-61. PubMed ID: 25552417
[TBL] [Abstract][Full Text] [Related]
18. Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions.
Swinstead EE; Miranda TB; Paakinaho V; Baek S; Goldstein I; Hawkins M; Karpova TS; Ball D; Mazza D; Lavis LD; Grimm JB; Morisaki T; Grøntved L; Presman DM; Hager GL
Cell; 2016 Apr; 165(3):593-605. PubMed ID: 27062924
[TBL] [Abstract][Full Text] [Related]
19. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
[TBL] [Abstract][Full Text] [Related]
20. FoxA1 is a key mediator of hormonal response in breast and prostate cancer.
Robinson JL; Carroll JS
Front Endocrinol (Lausanne); 2012; 3():68. PubMed ID: 22649425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]